Hepatic Failure Classification and Management
Introduction to Hepatic Failure
- The European Association for the Study of the Liver classifies hepatic failure into three main types: Type A (acute liver failure), Type B (portosystemic bypass/shunting), and Type C (cirrhosis-related) 1
Type B: Portosystemic Bypass/Shunting
- This type involves hepatic dysfunction resulting from portosystemic bypass without intrinsic liver disease, often due to congenital or acquired vascular abnormalities, and can manifest as hepatic encephalopathy despite relatively preserved liver function 1
Type C: Cirrhosis-related Liver Failure
- The European Association for the Study of the Liver defines acute decompensation (AD) as hospitalization required for an acute liver-related complication, stable decompensated cirrhosis (SDC) as patients discharged without readmission during 3-month follow-up, unstable decompensated cirrhosis (UDC) as patients with liver-related complications requiring readmission but not developing ACLF, and acute-on-chronic liver failure (ACLF) as acute deterioration of liver function in patients with pre-existing chronic liver disease 2
Acute-on-Chronic Liver Failure (ACLF)
- The EASL-CLIF-C definition of ACLF is based on organ failure assessment using the CLIF-SOFA score, graded as ACLF-1, ACLF-2, or ACLF-3 based on number of organ failures, and ACLF grading correlates directly with mortality risk 2, 3
- The APASL definition of ACLF is restricted to patients with acute liver dysfunction triggered by acute intrahepatic precipitants, and applies to patients with cirrhosis without prior decompensation and those with non-cirrhotic chronic liver disease 2, 3
Hepatic Encephalopathy Classification
- Hepatic encephalopathy is classified into four grades based on severity, including Grade I: shortened attention span, altered sleep rhythm, Grade II: inappropriate behavior, somnolence, Grade III: confusion, gross disorientation, and Grade IV: coma, no response to painful stimuli 1
Diagnostic Considerations
- The CLIF-SOFA score evaluates six major organ systems: liver (bilirubin), coagulation (INR), brain (encephalopathy), kidney (creatinine), circulation (blood pressure/vasopressors), and respiration (PaO2/FiO2 ratio) 3, 4
Management Principles
- The European Association for the Study of the Liver recommends early identification and treatment of precipitating factors, particularly for ACLF, and patients with ALF should be systematically referred to a liver transplant unit 4
- Liver transplantation remains the definitive treatment for patients with poor prognostic indicators, according to the European Association for the Study of the Liver 4
Decompensated Liver Failure Without Cirrhosis
Definition and Classification
- The Asia Pacific Association for the Study of the Liver defines acute-on-chronic liver failure to include patients with non-cirrhotic chronic liver disease who develop acute liver dysfunction triggered by intrahepatic precipitants 5
- The European Association for the Study of the Liver is not cited for a fact in this section, however, the APASL definition applies to patients with cirrhosis without prior decompensation AND those with chronic liver disease who have not yet developed cirrhosis 5
Non-Cirrhotic Pathways to Decompensation
- Patients with advanced fibrosis (F3 stage) can develop hepatic complications, though at lower rates than cirrhotic patients, with an intermediate annual HCC risk between early fibrosis and cirrhosis 6
Critical Clinical Distinctions
- The key distinction is that "decompensated cirrhosis" specifically requires underlying cirrhosis, while "decompensated liver failure" is a broader term encompassing any acute deterioration of hepatic function with clinical complications, regardless of whether cirrhosis is present 7, 5
Prognostic Implications
- Non-cirrhotic chronic liver disease with ACLF may have different organ failure patterns and precipitants than cirrhotic ACLF 5